119 related articles for article (PubMed ID: 37986355)
1. Network pharmacology and molecular docking study on the treatment of polycystic ovary syndrome with angelica sinensis- radix rehmanniae drug pair.
Li X; Ullah I; Hou C; Liu Y; Xiao K
Medicine (Baltimore); 2023 Nov; 102(46):e36118. PubMed ID: 37986355
[TBL] [Abstract][Full Text] [Related]
2. Using ultra-performance liquid chromatography with linear ion trap-electrostatic field orbitrap mass spectrometry, network pharmacology, and molecular docking to explore the constituent targets and action mechanisms of decoction of Angelica sinensis, Zingiberis Rhizoma Recens, and Mutton in the treatment of diarrhea-predominant irritable bowel syndrome.
Liu Z; Zheng Z; Wang T; Liu Z; Zuo Z
J Pharm Pharmacol; 2024 May; 76(5):462-478. PubMed ID: 37832514
[TBL] [Abstract][Full Text] [Related]
3. The effect of
Wang Q; Zhen W; Lippi G; Liu Q
Transl Androl Urol; 2024 Jan; 13(1):91-103. PubMed ID: 38404557
[TBL] [Abstract][Full Text] [Related]
4. [Study on mechanism of Rehmanniae Radix Praeparata for treatment of osteoarthritis based on network pharmacology and molecular docking].
Feng WQ; Liu KY; Zhang JN; Li YZ; Liu JL; Lu JQ; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5336-5343. PubMed ID: 36472041
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of
Wu M; Liu H; Zhang J; Dai F; Gong Y; Cheng Y
J Pharm Pharm Sci; 2023; 26():11234. PubMed ID: 36942296
[No Abstract] [Full Text] [Related]
6. [
Gao M; Hong Y; Cui M; Huang J; Tan Y; Nie X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):1-12. PubMed ID: 35249865
[TBL] [Abstract][Full Text] [Related]
7. Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.
Lin Y; Shen C; Wang F; Fang Z; Shen G
J Diabetes Res; 2021; 2021():9941791. PubMed ID: 34159207
[TBL] [Abstract][Full Text] [Related]
8. [Study on mechanism of Bushen Culuan Formula in treatment of polycystic ovary syndrome based on network pharmacology and molecular docking].
Ma K; Gong LJ; Chen YX; Tian CD
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2650-2659. PubMed ID: 34296561
[TBL] [Abstract][Full Text] [Related]
9. The effective compounds and mechanisms of Cang-Fu-Dao-Tan Formula in treating polycystic ovary syndrome based on UPLC/Q-TOF-MS/MS, network pharmacology and molecular experiments.
Hu W; Xie N; Zhu H; Jiang Y; Ding S; Ye S; Zhang S; Wang F; Qu F; Zhou J
J Pharm Biomed Anal; 2024 Feb; 239():115867. PubMed ID: 38061171
[TBL] [Abstract][Full Text] [Related]
10. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
Yu J; Fu Y; Zeng L; Zheng Y
Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of modified Huanglian Wendan decoction in the treatment of polycystic ovary syndrome.
Wu Z; Yang T; Ma H
Medicine (Baltimore); 2023 Apr; 102(15):e33212. PubMed ID: 37058016
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury.
Cao S; Hou G; Meng Y; Chen Y; Xie L; Shi B
Dis Markers; 2022; 2022():2141882. PubMed ID: 36157206
[TBL] [Abstract][Full Text] [Related]
13. Prediction and validation of potential molecular targets for the combination of Astragalus membranaceus and Angelica sinensis in the treatment of atherosclerosis based on network pharmacology.
Wang T; Zhou Y; Wang K; Jiang X; Wang J; Chen J
Medicine (Baltimore); 2022 Jul; 101(26):e29762. PubMed ID: 35776988
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.
Dong Y; Zhao Q; Wang Y
Sci Rep; 2021 Sep; 11(1):19496. PubMed ID: 34593896
[TBL] [Abstract][Full Text] [Related]
15. Exploring the mechanism and experimental validation of Fuzi Lizhong Tang in treating gastric cancer based on network pharmacology and molecular docking.
Zhang FY; Guo SC
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9192-9204. PubMed ID: 37843333
[TBL] [Abstract][Full Text] [Related]
16. Analyzing network pharmacology and molecular docking to clarify Duhuo Jisheng decoction potential mechanism of osteoarthritis mitigation.
Cui Z; Zhang W; Le X; Song K; Zhang C; Zhao W; Sha L
Medicine (Baltimore); 2022 Dec; 101(50):e32132. PubMed ID: 36550856
[TBL] [Abstract][Full Text] [Related]
17. A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance.
Shi N; Zhou Y; Ma H
Medicine (Baltimore); 2022 Dec; 101(48):e32057. PubMed ID: 36482532
[TBL] [Abstract][Full Text] [Related]
18. [Anti-rheumatoid arthritis mechanism of Sophorae Tonkinesis Radix et Rhizoma based on network pharmacology and experimental verification].
Zhu PP; Qi MZ; Yang JH; Tao XY; Lin N; Su XH; Kong XY
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5327-5335. PubMed ID: 36472040
[TBL] [Abstract][Full Text] [Related]
19. Exploring the mechanism of Ginkgo biloba L. leaves in the treatment of vascular dementia based on network pharmacology, molecular docking, and molecular dynamics simulation.
Pan J; Tang J; Gai J; Jin Y; Tang B; Fan X
Medicine (Baltimore); 2023 May; 102(21):e33877. PubMed ID: 37233418
[TBL] [Abstract][Full Text] [Related]
20. Study on the mechanism of ErtongKe granules in the treatment of cough using network pharmacology and molecular docking technology.
Chen YL; Li WX; Zhang H; Wang XY; Zhang SQ; Zhang ML; Han J; Li K; Feng KR; Chen XF; Tang JF
Ann Palliat Med; 2021 Nov; 10(11):11415-11429. PubMed ID: 34872267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
